Literature DB >> 20861226

PPARgamma-dependent regulation of adenylate cyclase 6 amplifies the stimulatory effect of cAMP on renin gene expression.

Michael Desch1, Thomas Schubert, Andrea Schreiber, Sandra Mayer, Björn Friedrich, Ferruh Artunc, Vladimir T Todorov.   

Abstract

The second messenger cAMP plays an important role in the regulation of renin gene expression. Nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ) is known to stimulate renin gene transcription acting through PPARγ-binding sequences in renin promoter. We show now that activation of PPARγ by unsaturated fatty acids or thiazolidinediones drastically augments the cAMP-dependent increase of renin mRNA in the human renin-producing cell line Calu-6. The underlying mechanism involves potentiation of agonist-induced cAMP increase and up-regulation of adenylate cyclase 6 (AC6) gene expression. We identified a palindromic element with a 3-bp spacer (Pal3) in AC6 intron 1 (AC6Pal3). AC6Pal3 bound PPARγ and mediated trans-activation by PPARγ agonist. AC6 knockdown decreased basal renin mRNA level and attenuated the maximal PPARγ-dependent stimulation of the cAMP-induced renin gene expression. AC6Pal3 decoy oligonucleotide abrogated the PPARγ-dependent potentiation of cAMP-induced renin gene expression. Treatment of mice with PPARγ agonist increased AC6 mRNA kidney levels. Our data suggest that in addition to its direct effect on renin gene transcription, PPARγ "sensitizes" renin gene to cAMP via trans-activation of AC6 gene. AC6 has been identified as PPARγ target gene with a functional Pal3 sequence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861226      PMCID: PMC5417377          DOI: 10.1210/me.2010-0134

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  40 in total

1.  The calcium paradoxon of renin release: calcium suppresses renin exocytosis by inhibition of calcium-dependent adenylate cyclases AC5 and AC6.

Authors:  Christian Grünberger; Birgit Obermayer; Jürgen Klar; Armin Kurtz; Frank Schweda
Journal:  Circ Res       Date:  2006-10-26       Impact factor: 17.367

2.  The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Authors:  A Bonen; N N Tandon; J F C Glatz; J J F P Luiken; G J F Heigenhauser
Journal:  Int J Obes (Lond)       Date:  2006-06       Impact factor: 5.095

3.  Dual DNA-binding specificity of peroxisome-proliferator-activated receptor gamma controlled by heterodimer formation with retinoid X receptor alpha.

Authors:  M Okuno; E Arimoto; Y Ikenobu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

4.  Gene expression of prostanoid forming enzymes along the rat nephron.

Authors:  Helga Vitzthum; Ilona Abt; Stefan Einhellig; Armin Kurtz
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

Review 5.  Regulation of renin: new evidence from cultured cells and genetically modified mice.

Authors:  M Bader; D Ganten
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

6.  Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.

Authors:  Ferruh Artunc; Diana Sandulache; Omaima Nasir; Krishna M Boini; Björn Friedrich; Norbert Beier; Edith Dicks; Sven Pötzsch; Karin Klingel; Kerstin Amann; Bonnie L Blazer-Yost; Wolfgang Scholz; Teut Risler; Dietmar Kuhl; Florian Lang
Journal:  Pflugers Arch       Date:  2008-01-03       Impact factor: 3.657

7.  Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression.

Authors:  Vladimir T Todorov; Michael Desch; Nina Schmitt-Nilson; Anelia Todorova; Armin Kurtz
Journal:  Hypertension       Date:  2007-09-04       Impact factor: 10.190

8.  Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells.

Authors:  Michael Desch; Andrea Schreiber; Frank Schweda; Kirsten Madsen; Ulla G Friis; Eric T Weatherford; Curt D Sigmund; Maria Luisa Sequeira Lopez; R Ariel Gomez; Vladimir T Todorov
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

9.  Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.

Authors:  Matthias Hautmann; Ulla G Friis; Michael Desch; Vladimir Todorov; Hayo Castrop; Florian Segerer; Christiane Otto; Günther Schütz; Frank Schweda
Journal:  J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 10.121

10.  Dissecting the action of an evolutionary conserved non-coding region on renin promoter activity.

Authors:  Ralf Mrowka; Andreas Steege; Charlotte Kaps; Hanspeter Herzel; Bernd J Thiele; Pontus B Persson; Nils Blüthgen
Journal:  Nucleic Acids Res       Date:  2007-07-26       Impact factor: 16.971

View more
  11 in total

1.  Interference with Gsα-Coupled Receptor Signaling in Renin-Producing Cells Leads to Renal Endothelial Damage.

Authors:  Peter Lachmann; Linda Hickmann; Anne Steglich; Moath Al-Mekhlafi; Michael Gerlach; Niels Jetschin; Steffen Jahn; Brigitte Hamann; Monika Wnuk; Kirsten Madsen; Valentin Djonov; Min Chen; Lee S Weinstein; Bernd Hohenstein; Christian P M Hugo; Vladimir T Todorov
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  Chicken ovalbumin upstream promoter transcription factor II regulates renin gene expression.

Authors:  Sandra Mayer; Marc Roeser; Peter Lachmann; Sumiyashi Ishii; Jae Mi Suh; Sabine Harlander; Michael Desch; Coy Brunssen; Henning Morawietz; Sophia Y Tsai; Ming-Jer Tsai; Bernd Hohenstein; Christian Hugo; Vladimir T Todorov
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  cAMP target sequences enhCRE and CNRE sense low-salt intake to increase human renin gene expression in vivo.

Authors:  Michael Desch; Sabine Harlander; Björn Neubauer; Melanie Gerl; Stephane Germain; Hayo Castrop; Vladimir T Todorov
Journal:  Pflugers Arch       Date:  2011-03-22       Impact factor: 3.657

4.  The PPAR-gamma-binding sequence Pal3 is necessary for basal but dispensable for high-fat diet regulated human renin expression in the kidney.

Authors:  Peter Lachmann; Jenny Selbmann; Linda Hickmann; Bernd Hohenstein; Christian Hugo; Vladimir T Todorov
Journal:  Pflugers Arch       Date:  2017-05-22       Impact factor: 3.657

5.  Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis.

Authors:  Keizo Matsushita; Hai-Chun Yang; Manu M Mysore; Jianyong Zhong; Yu Shyr; Li-Jun Ma; Agnes B Fogo
Journal:  Lab Invest       Date:  2016-03-21       Impact factor: 5.662

6.  Renin cells with defective Gsα/cAMP signaling contribute to renal endothelial damage.

Authors:  Anne Steglich; Friederike Kessel; Linda Hickmann; Michael Gerlach; Peter Lachmann; Florian Gembardt; Mathias Lesche; Andreas Dahl; Anna Federlein; Frank Schweda; Christian P M Hugo; Vladimir T Todorov
Journal:  Pflugers Arch       Date:  2019-08-06       Impact factor: 3.657

Review 7.  Control of renin [corrected] gene expression.

Authors:  Sean T Glenn; Craig A Jones; Kenneth W Gross; Li Pan
Journal:  Pflugers Arch       Date:  2012-05-11       Impact factor: 3.657

8.  Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model.

Authors:  Cristina Martínez-García; Adriana Izquierdo; Vidya Velagapudi; Yurena Vivas; Ismael Velasco; Mark Campbell; Keith Burling; Fernando Cava; Manuel Ros; Matej Oresic; Antonio Vidal-Puig; Gema Medina-Gomez
Journal:  Dis Model Mech       Date:  2012-07-05       Impact factor: 5.758

Review 9.  PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance.

Authors:  Vladimir T Todorov
Journal:  PPAR Res       Date:  2013-10-30       Impact factor: 4.964

10.  Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.

Authors:  Christopher P Stanley; Saoirse E O'Sullivan
Journal:  Pharmacol Res       Date:  2014-02-16       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.